Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

about

CAR-T Cell Therapy: From the Bench to the Bedside.Cancer immunotherapy beyond immune checkpoint inhibitors.

P2860

Q47121638-747220B9-98C5-45CB-A429-DC509DD3C260 Q47554248-8D433632-FA33-4B14-96A0-EC33C815CD43

P2860

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

Item

http://www.wikidata.org/entity/Q38399051

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

@en

type

Item

label

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

@en

prefLabel

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

@en

P1476

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)

@en

P2093

Andrew R Haas

http://www.w3.org/2001/XMLSchema#string

Edmund K Moon

http://www.w3.org/2001/XMLSchema#string

Steven M Albelda

http://www.w3.org/2001/XMLSchema#string

P2860

Malignant Mesothelioma: Global Incidence and Relationship with Asbestos

Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Cancer immunoediting from immune surveillance to immune escape

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Clinical manufacturing of CAR T cells: foundation of a promising therapy

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Antagonists of PD-1 and PD-L1 in Cancer Treatment

Malignant mesothelioma mortality - United States, 1999--2015

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

P31

scholarly article

P356

10.3390/CANCERS9090115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Astero Klampatsa

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28862644

http://www.w3.org/2001/XMLSchema#string

P932

5615330

http://www.w3.org/2001/XMLSchema#string

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

about

P2860

P2860

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932